NAGE
insider transactionsNiagen Bioscience, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Exercise·M
Robert N Fried KEY
Chief Executive Officer
$0
20.0K sh
Own New
-
Exercise·M
Robert N Fried KEY
Chief Executive Officer
$52.2K
20.0K sh · $2.61
Own +2%
-
Grant·A
Ozan Pamir KEY
Chief Financial Officer
$0
62.1K sh
Own New
-
Grant·A
SVP, General Counsel
$0
41.4K sh
Own New
-
Grant·A
Robert N Fried KEY
Chief Executive Officer
$0
503.9K sh
Own New
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Apr 24, 2026 | Robert N Fried KEY | Exercise M | 20.0K | $0 |
| Apr 24, 2026 | Robert N Fried KEY | Exercise M | 20.0K | $52.2K |
| Feb 19, 2026 | Ozan Pamir KEY | Grant A | 62.1K | $0 |
| Feb 19, 2026 | Carlos Luis Lopez | Grant A | 41.4K | $0 |
| Feb 19, 2026 | Robert N Fried KEY | Grant A | 503.9K | $0 |
About NAGE insider trading
This page tracks insider transactions for Niagen Bioscience, Inc. (NAGE) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.